¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"senile degeneration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • axonal degeneration
    Ãà»èº¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÇà
  • disciform macular degeneration
    ¿ø¹ÝȲ¹Ýº¯¼º
  • elastotic degeneration
    ź·Â¼¶À¯º¯¼º
  • fatty degeneration
    Áö¹æº¯¼º
  • fibrinoid degeneration
    ¼¶À¯¼Ò¸ð¾çº¯¼º, ÇǺ기¸ð¾çº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • malignant degeneration
    ¾Ç¼ºº¯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • angiolithic degeneration
    ¸Æ°ü°á¼®º¯¼º, Ç÷°üµ¹º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cobblestone degeneration
    ÀÚ°¥¸ð¾çº¯¼º, Á¶¾àµ¹º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÇà
  • disciform macular degeneration
    ¿ø¹ÝȲ¹Ýº¯¼º
  • elastotic degeneration
    ź·Â¼¶À¯º¯¼º
  • endoglobular degeneration
    Ç÷±¸³»º¯¼º
  • equatorial degeneration
    Àûµµº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hepatocereberal degeneration
    °£³úº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º.
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º.
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º
  • hereditary macular degeneration
    À¯Àü¼º Ȳ¹Ýº¯¼º(ë¶îîàõüÜÚèܨàõ).
  • hyaline corneal degeneration
    À¯¸®Áú°¢¸·º¯¼º, È÷¾Ë¸°°¢¸·º¯¼º
  • hyaline degeneration
    À¯¸®Áúº¯¼º, È÷¾Ë¸°º¯¼º
  • hyaline degeneration
    À¯¸®Áú º¯¼º
  • hyaline degeneration,zenkers
    笀  • hyaloideoretinal degeneration
    À¯¸®Ã¼¸Á¸·º¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • lenticular degeneration
    ·»ÁîÇÙº¯¼º(Áõ)(¡­ú·Ü¨àõñø).
  • liquefaction degeneration
    ¾×È­ º¯¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SK seborrheic keratosis; senile keratosis; Sloan-Kettering [Institute for Cancer Research]; spontaneous...
SP sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]...
sP senile parkinsonism
ARMD Age-Related Macular Degeneration; ³ëÀμº Ȳ¹Ý Çü¼º
CMD Cerebro-Macular Degeneration
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
Mnd Motor neuron degeneration
NFD Neurofibrillary degeneration
PCD Paraneoplastic cerebellar degeneration
prcd Progressive rod-cone degeneration
PCD Purkinje Cell Degeneration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • colloid degeneration
    ÄÝ·ÎÀÌµå º¯¼º
  • corneal degeneration
    °¢¸· º¯¼º
  • cystic degeneration
    ³¶»ó º¯¼º, ³¶Á¾ º¯¼º
  • cystoid degeneration
    À¯³¶»ó º¯¼º
  • degeneration of pulp
    Ä¡¼öÀÇ ÅðÈ­
    ³ëÈ­ µîÀÇ ¿µÇâÀ¸·Î Ä¡¼ö°¡ À§ÃàµÇ°í Ä¡¼ö°­ÀÌ Á¼¾ÆÁö´Â °Í.
  • disk degeneration
    ¿øÆÇ º¯¼º
  • fat degeneration
    Áö¹æ º¯¼º
  • fibrinoid degeneration
    ¼¶À¯¼Ò¾ç º¯¼º, ¼¶À¯¾ç º¯¼º
    µ¿ÀǾî=fibrinoid swelling.
  • hyaline degeneration
    À¯¸®Áú º¯¼º
    ¼¼Æ÷ÁúÀÌ ±ÕÁúÀÌ À¯¸® ¸ð¾çÀΠȣ»ê¼ºÀÇ ¸ð¾çÀ» ³ªÅ¸³»´Â ÅðÇ༺ ¼¼Æ÷ º¯È­.
  • joint degeneration
    °üÀý ÅðÇà
  • liquefactive degeneration
    ¾×È­ º¯¼º
  • malignant degeneration
    ¾Ç¼ºÈ­
  • mosaic corneal degeneration
    ¸ðÀÚÀÌÅ© °¢¸· º¯¼º
  • myocardial degeneration
    ½É±Ù º¯¼º
  • myopic degeneration
    ±Ù½Ã¼º º¯¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
senile plaque <neurology> Characteristic feature of the brains of Alzheimer's patients and aged monkeys, consisting of a core of amyloid fibrils surrounded by dystrophic neurites.
The principal component of amyloid fibrils in senile plaques is B/A4, a peptide of about 4 kD that is derived from the larger amyloid precursor protein (APP). The B/A4 sequence is located near the C terminus of APP.
(18 Nov 1997)
senile plaques Microscopic argyrophilic masses composed of fragmented axon terminals and dendrites surrounding a core of amyloid. They are seen in small amounts in the cerebral cortex of normal elderly people and in larger amounts in those with alzheimer disease.
(12 Dec 1998)
senile psychosis Mental disturbance occurring in old age and related to degenerative cerebral processes.
(05 Mar 2000)
senile retinoschisis Retinoschisis occurring most often in the elderly and affecting the outer plexiform layer; it begins in the extreme inferotemporal periphery and is not significantly progressive; vision usually is good.
(05 Mar 2000)
senile sebaceous hyperplasia Hyperplasia of mature sebaceous glands, forming a nodule on the skin of the face or forehead in elderly persons.
(05 Mar 2000)
senile tremor An essential tremor that becomes symptomatic in elderly adults.
(05 Mar 2000)
senile wart <dermatology> A skin lesion that is abnormally sensitive to the effects of ultraviolet light (sunlight). Thought to be a precancerous skin lesion that is more common in the fair-skinned or elderly individual.
Approximately 20% of these skin lesions will develop into squamous cell carcinoma. Prevention includes the use of sun screen agents and the avoidance of drugs (for example tetracyclines) known to cause photosensitivity reactions.
Usually a discreet slightly raised, red or pink lesion located on a sun exposed surface. Texture may appear as rough, gritty or scaly. Growths may be biopsied to look for cancer or removed via cryotherapy or electrical cautery. Some topical agents may be used to promote peeling.
(27 Sep 1997)
adipose degeneration Abnormal formation of microscopically visible droplets of fat in the cytoplasm of cells, as a result of injury.
Synonym: adipose degeneration, steatosis.
(05 Mar 2000)
adiposogenital degeneration A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
albuminous degeneration An obsolete terms for cloudy swelling.
(05 Mar 2000)
amyloid degeneration Infiltration of amyloid between cells and fibres of tissues and organs.
Synonym: waxy degeneration.
(05 Mar 2000)
angiolithic degeneration Calcareous degeneration of the walls of the blood vessels.
(05 Mar 2000)
ascending degeneration Retrograde degeneration of an injured nerve fibre; i.e., toward the nerve cell of the fibre, degeneration cephalad to a spinal cord lesion.
(05 Mar 2000)
atheromatous degeneration Focal accumulation of lipid material (atheroma) in the intima and subintimal portion of arteries, eventually resulting in fibrous thickening or calcification.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á